These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 20846107)

  • 1. Matrix metalloproteinases.
    Zitka O; Kukacka J; Krizkova S; Huska D; Adam V; Masarik M; Prusa R; Kizek R
    Curr Med Chem; 2010; 17(31):3751-68. PubMed ID: 20846107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in matrix metalloproteinase research.
    Murphy G; Nagase H
    Mol Aspects Med; 2008 Oct; 29(5):290-308. PubMed ID: 18619669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metalloproteinases. Structure and function].
    Lipka D; Boratyński J
    Postepy Hig Med Dosw (Online); 2008 Jul; 62():328-36. PubMed ID: 18614970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and function of matrix metalloproteinases and TIMPs.
    Nagase H; Visse R; Murphy G
    Cardiovasc Res; 2006 Feb; 69(3):562-73. PubMed ID: 16405877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases in tumor invasion.
    Johansson N; Ahonen M; Kähäri VM
    Cell Mol Life Sci; 2000 Jan; 57(1):5-15. PubMed ID: 10949577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
    Visse R; Nagase H
    Circ Res; 2003 May; 92(8):827-39. PubMed ID: 12730128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Matrix metalloproteinases and their tissue inhibitors].
    Trojanek J
    Postepy Biochem; 2012; 58(3):353-62. PubMed ID: 23373420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel therapeutic approaches targeting matrix metalloproteinases in cardiovascular disease.
    Briasoulis A; Tousoulis D; Papageorgiou N; Kampoli AM; Androulakis E; Antoniades C; Tsiamis E; Latsios G; Stefanadis C
    Curr Top Med Chem; 2012; 12(10):1214-21. PubMed ID: 22519451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metalloproteinase inhibitors: biological actions and therapeutic opportunities.
    Baker AH; Edwards DR; Murphy G
    J Cell Sci; 2002 Oct; 115(Pt 19):3719-27. PubMed ID: 12235282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?
    Janssens S; Lijnen HR
    Cardiovasc Res; 2006 Feb; 69(3):585-94. PubMed ID: 16426591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix turnover.
    Kerrigan JJ; Mansell JP; Sandy JR
    J Orthod; 2000 Sep; 27(3):227-33. PubMed ID: 11099555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Series "matrix metalloproteinases in lung health and disease": Biological role of matrix metalloproteinases: a critical balance.
    Löffek S; Schilling O; Franzke CW
    Eur Respir J; 2011 Jul; 38(1):191-208. PubMed ID: 21177845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical and Biological Attributes of Matrix Metalloproteinases.
    Cui N; Hu M; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 147():1-73. PubMed ID: 28413025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multilevel regulation of matrix metalloproteinases in tissue homeostasis indicates their molecular specificity in vivo.
    Gaffney J; Solomonov I; Zehorai E; Sagi I
    Matrix Biol; 2015; 44-46():191-9. PubMed ID: 25622911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases and their inhibitors in bone: an overview of regulation and functions.
    Varghese S
    Front Biosci; 2006 Sep; 11():2949-66. PubMed ID: 16720367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RECK, a novel matrix metalloproteinase regulator.
    Meng N; Li Y; Zhang H; Sun XF
    Histol Histopathol; 2008 Aug; 23(8):1003-10. PubMed ID: 18498076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of matrix metalloproteinases in cardiovascular diseases].
    Groblewska M; Tycińska A; Mroczko B; Musiał W; Szmitkowski M
    Pol Merkur Lekarski; 2011 Apr; 30(178):235-40. PubMed ID: 21595165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting.
    Abdel-Hamid NM; Abass SA
    Mol Biol Rep; 2021 Sep; 48(9):6525-6538. PubMed ID: 34379286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dm1-MMP, a matrix metalloproteinase from Drosophila with a potential role in extracellular matrix remodeling during neural development.
    Llano E; Pendás AM; Aza-Blanc P; Kornberg TB; López-Otín C
    J Biol Chem; 2000 Nov; 275(46):35978-85. PubMed ID: 10964925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour microenvironment - opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy.
    Overall CM; Kleifeld O
    Nat Rev Cancer; 2006 Mar; 6(3):227-39. PubMed ID: 16498445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.